In cervical cancer, ARAP1-AS1 is enhanced in tumor samples, and ARAP1-AS1 overexpression enhances the viability, migration, and invasion of tumor cells via downregulating microRNA-149-3p and elevating the expression of POU class 2 homeobox 2 [36]. Here, POU2F2 is linked to cervical carcinoma.